On 27th March, the commendation conference for the COVID-19 vaccine project partners was held by China Biotechnology Co., Ltd. of Sinopharm in Beijing. AUSTAR Group has been recognized by Beijing Institute of Biological Products affiliated Sinopharm and won the Outstanding Contribution Award for our excellent performance in the construction of COVID-19 vaccine project.
During the pandemic, AUSTAR has undertaken the project of constructing COVID-19 vaccine workshop. Based on 30 years of pharmaceutical industry experience, we provided pharmaceutical fluid process system, clean room key environmental monitoring system(EMS), supervisory control and data acquisition(SCADA) and single-use mixing system that met the biosafety level, and completed the construction of the project in only 2 months. The construction of the project not only complied with the current requirements of China GMP, but also reached the WHO pre-certification level.
The quality and efficiency of AUSTAR effectively ensured the smooth development and production of COVID-19 vaccine, and made positive social contributions to the protection of national public health and safety.